Literature DB >> 28552906

Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.

A M Heilmann1, A B Schrock1, J He1, M Nahas1, K Curran2, N Shukla2, S Cramer3, L Draper4, A Verma4, R Erlich1, J Ross1,5, P Stephens1, V A Miller1, S M Ali1, J-A Verglio1, M S Tallman2, T I Mughal1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28552906     DOI： 10.1038/leu.2017.161

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Authors:  Brent W Weston; Melissa A Hayden; Kathryn G Roberts; Susan Bowyer; Johann Hsu; George Fedoriw; Kathleen W Rao; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

2.  Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.

Authors:  Etienne Lengline; Kheïra Beldjord; Hervé Dombret; Jean Soulier; Nicolas Boissel; Emmanuelle Clappier
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

3.  Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.

Authors:  Jie He; Omar Abdel-Wahab; Michelle K Nahas; Kai Wang; Raajit K Rampal; Andrew M Intlekofer; Jay Patel; Andrei Krivstov; Garrett M Frampton; Lauren E Young; Shan Zhong; Mark Bailey; Jared R White; Steven Roels; Jason Deffenbaugh; Alex Fichtenholtz; Timothy Brennan; Mark Rosenzweig; Kimberly Pelak; Kristina M Knapp; Kristina W Brennan; Amy L Donahue; Geneva Young; Lazaro Garcia; Selmira T Beckstrom; Mandy Zhao; Emily White; Vera Banning; Jamie Buell; Kiel Iwanik; Jeffrey S Ross; Deborah Morosini; Anas Younes; Alan M Hanash; Elisabeth Paietta; Kathryn Roberts; Charles Mullighan; Ahmet Dogan; Scott A Armstrong; Tariq Mughal; Jo-Anne Vergilio; Elaine Labrecque; Rachel Erlich; Christine Vietz; Roman Yelensky; Philip J Stephens; Vincent A Miller; Marcel R M van den Brink; Geoff A Otto; Doron Lipson; Ross L Levine
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

4.  SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells.

Authors:  Tom L Stephen; Kyle K Payne; Ricardo A Chaurio; Michael J Allegrezza; Hengrui Zhu; Jairo Perez-Sanz; Alfredo Perales-Puchalt; Jenny M Nguyen; Ana E Vara-Ailor; Evgeniy B Eruslanov; Mark E Borowsky; Rugang Zhang; Terri M Laufer; Jose R Conejo-Garcia
Journal:  Immunity       Date:  2017-01-17       Impact factor: 31.745

Review 5.  Genetic Basis of Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

6.  Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.

Authors:  Idoya Lahortiga; Cem Akin; Jan Cools; Todd M Wilson; Nicole Mentens; Diane C Arthur; Irina Maric; Pierre Noel; Can Kocabas; Peter Marynen; Lawrence S Lessin; Iwona Wlodarska; Jamie Robyn; Dean D Metcalfe
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 7.  Dedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development.

Authors:  Xia Guo; Shi-You Chen
Journal:  J Cell Physiol       Date:  2017-02-28       Impact factor: 6.384

8.  AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis.

Authors:  Yu Liu; Hui Yang; Lina Song; Nan Li; Qiu-Yue Han; Cui Tian; Erhe Gao; Jie Du; Yun-Long Xia; Hui-Hua Li
Journal:  Apoptosis       Date:  2014-08       Impact factor: 4.677

9.  SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

Authors:  Guiqin Song; Kang Liu; Xiaolin Yang; Bo Mu; Junbao Yang; Lang He; Xin Hu; Qiujiang Li; Yunxia Zhao; Xiaoming Cai; Gang Feng
Journal:  Oncotarget       Date:  2017-03-14

10.  EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.

Authors:  Claire Schwab; Sarra L Ryan; Lucy Chilton; Alannah Elliott; James Murray; Stacey Richardson; Christopher Wragg; John Moppett; Michelle Cummins; Oliver Tunstall; Catriona A Parker; Vaskar Saha; Nicholas Goulden; Ajay Vora; Anthony V Moorman; Christine J Harrison
Journal:  Blood       Date:  2016-02-12       Impact factor: 22.113
View more
  5 in total

Review 1.  Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Jason Gotlib; Ruben Mesa; Steffen Koschmieder; H Jean Khoury; Jorge E Cortes; Tiziano Barbui; Rüdiger Hehlmann; Michael Mauro; Susanne Saussele; Jerald P Radich; Richard A Van Etten; Giuseppe Saglio; Srdnan Verstovek; Robert Peter Gale; Omar Abdel-Wahab
Journal:  Leuk Res       Date:  2018-02-14       Impact factor: 3.156

2.  PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.

Authors:  Yingchi Zhang; Yufeng Gao; Hui Zhang; Jingliao Zhang; Fuhong He; Aleš Hnízda; Maoxiang Qian; Xiaoming Liu; Yoshihiro Gocho; Ching-Hon Pui; Tao Cheng; Qianfei Wang; Jun J Yang; Xiaofan Zhu; Xin Liu
Journal:  Blood       Date:  2018-02-06       Impact factor: 25.476

Review 3.  Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.

Authors:  Anna Mroczek; Joanna Zawitkowska; Jerzy Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

4.  Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.

Authors:  Danika Di Giacomo; Martina Quintini; Valentina Pierini; Fabrizia Pellanera; Roberta La Starza; Paolo Gorello; Caterina Matteucci; Barbara Crescenzi; Paolo Fabio Fiumara; Marinella Veltroni; Erika Borlenghi; Francesco Albano; Fabio Forghieri; Monica Maccaferri; Francesca Bettelli; Mario Luppi; Antonio Cuneo; Giuseppe Rossi; Cristina Mecucci
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673

Review 5.  Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.

Authors:  Claudia Fiñana; Noel Gómez-Molina; Sandra Alonso-Moreno; Laura Belver
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.